Vertex Pharmaceuticals
VRTX
VRTX
736 hedge funds and large institutions have $45.2B invested in Vertex Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 96 funds opening new positions, 293 increasing their positions, 226 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 705 → 736 (+31)
0.76% more ownership
Funds ownership: 95.46% → 96.21% (+0.76%)
19% less funds holding in top 10
Funds holding in top 10: 16 → 13 (-3)
Holders
736
Holding in Top 10
13
Calls
$303M
Puts
$244M
Top Buyers
| 1 | +$727M | |
| 2 | +$190M | |
| 3 | +$138M | |
| 4 |
Renaissance Technologies
New York
|
+$137M |
| 5 |
State Street
Boston,
Massachusetts
|
+$118M |
Top Sellers
| 1 | -$365M | |
| 2 | -$150M | |
| 3 | -$137M | |
| 4 |
FAM
Fred Alger Management
New York
|
-$114M |
| 5 |
Millennium Management
New York
|
-$114M |